Nyanti L E, Huan N-C, Ramarmurty H Y, Renganathan T, Bin Abdul Aziz M A, Low J L, Rosli K T, Letcheminan S, Lansing M G, Sivaraman Kannan K K
Medical Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
Department of Respiratory Medicine, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia.
Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e1149. doi: 10.7196/AJTCCM.2023.v29i4.1149. eCollection 2023.
Pleural fluid residue, or macroscopic tissue, circulating freely in the pleural fluid obtained through direct filtration, may carry diagnostic histopathological information. We aimed to determine the histopathological concordance of pleural fluid residue in diagnosing TPE and MPE, compared with conventional pleural biopsy. This was a prospective cohort study of consecutive inpatients with cytology-negative exudative effusion who underwent pleuroscopy and had their initial suctioned pleural fluid filtered for residue samples. Pleural fluid residue demonstrated malignant cells in four out of seven cases of pleural biopsy-confirmed malignancy. Pleural fluid residue has comparable cytomorphology but reduced cellularity compared with pleural biopsy. No tuberculous histological features were present in the pleural fluid residue samples. In this preliminary study pleural fluid residue provided histopathological information for malignant pleural effusion, but no incremental diagnostic information for tuberculous effusion. However larger and more definitive studies are required to clarify these findings, and to explore the utility and suitability of pleural fluid residue for mutational analysis.
This study demonstrates the potential of pleural fluid residue as a non-invasive diagnostic method for confirming malignancy in cytology-negative exudative effusion.
In resource-limited settings or patients contraindicated for pleural biopsy, pleural fluid residue may provide a viable diagnostic alternative; however, this observation needs further validation.
通过直接过滤获得的胸腔积液中自由循环的胸腔积液残渣或宏观组织可能携带诊断性组织病理学信息。我们旨在确定与传统胸腔活检相比,胸腔积液残渣在诊断结核性胸膜炎(TPE)和恶性胸腔积液(MPE)中的组织病理学一致性。这是一项对连续住院的细胞学检查阴性的渗出性胸腔积液患者进行的前瞻性队列研究,这些患者接受了胸腔镜检查,并对其最初抽取的胸腔积液进行过滤以获取残渣样本。在7例经胸腔活检确诊为恶性肿瘤的病例中,有4例胸腔积液残渣显示出恶性细胞。与胸腔活检相比,胸腔积液残渣具有可比的细胞形态,但细胞数量减少。胸腔积液残渣样本中未发现结核的组织学特征。在这项初步研究中,胸腔积液残渣为恶性胸腔积液提供了组织病理学信息,但对结核性胸腔积液没有增加诊断信息。然而,需要更大规模和更明确的研究来阐明这些发现,并探索胸腔积液残渣用于突变分析的实用性和适用性。
本研究证明了胸腔积液残渣作为一种非侵入性诊断方法在确诊细胞学检查阴性的渗出性胸腔积液中的恶性肿瘤方面的潜力。
在资源有限的环境或禁忌进行胸腔活检的患者中,胸腔积液残渣可能提供一种可行的诊断替代方法;然而,这一观察结果需要进一步验证。